Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06161207 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer

Study acronym: 3D-4K-ICG
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 24, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 1, 2024 to Jan 3, 2023
    v3
  2. Start date: Dec 1, 2023 to Jan 1, 2024
    • Primary completion date: Dec 1, 2025 to Jan 1, 2026
    • Study completion date: Dec 1, 2028 to Jan 1, 2029
    • Study title shortened, about 12 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients with locally advanced gastric adenocarcinoma (CT2-4a N-/+ M0) were selected as study subjects to investigate the safety, efficacy, and feasibility of ICG near-infrared imaging tracing in 3D plus ultra high resolution laparoscopic gastrectomy with lymph node dissection for gastric cancer.
Trial Details
NCT Number NCT06161207
Lead Sponsor Fujian Medical University
Conditions
(from sponsor)		 Gastric Cancer, Surgery
Related terms Stomach Neoplasms
Enrollment 702 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov